📰 Track Designation News
Track Designation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Track Designation. Real-time updates on events, politics, business and more.
June 13, 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...
May 29, 2024
May 29, 2024 Company Name: AnGes Inc. Presentative: Ei Yamada, President & CEO Tie2 receptor agonist ,co-development...
May 29, 2024
/PRNewswire/ -- SpliSense, a clinical-stage biotechnology company focused on the development of transformative RNA-based therapies for pulmonary diseases...
May 29, 2024
Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response and two stable disease observations have occurred as of May 15,...
May 23, 2024
Median overall survival of 20.6 months was observed following two administrations of CAN-2409 + valacyclovir in NSCLC patients with progressive disease despite immune checkpoint inhibitor therapy...
May 23, 2024
Emerging clinical pharmacokinetic and safety profiles of Bicycle Toxin Conjugates demonstrate differentiation compared to antibody drug conjugates Trial-in-progress poster outlines registrational
May 23, 2024
23.05.2024 - Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today announced that emerging Phase 1/2 clinical ... Seite 1
May 23, 2024
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--May 23, 2024--
May 22, 2024
VBI Vaccines Inc. , a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new interim tumor response data from the...
May 21, 2024
Regulatory News: Innate Pharma SA today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by Sanofi, it...